β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

• 收藏
• 分享

专利权人:

Atea Pharmaceuticals; Inc.

发明人:

Jean-Pierre Sommadossi,Adel Moussa

申请号：

US15782628

公开号：

US10000523B2

申请日:

2017.10.12

申请国别(地区):

US

年份:

2018

代理人:

摘要：

A compound of the structure:or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/